Literature DB >> 9693097

Role for protein phosphatases in the cell-cycle-regulated phosphorylation of stathmin.

S J Mistry1, H C Li, G F Atweh.   

Abstract

Stathmin is a major cytosolic phosphoprotein that regulates microtubule dynamics during the assembly of the mitotic spindle. The activity of stathmin itself is regulated by changes in its state of phosphorylation during the transition from interphase to metaphase. For a better understanding of the regulation of stathmin activity during the cell cycle, we explored the mechanism(s) responsible for the decrease in the level of phosphorylation of stathmin as cells complete mitosis and enter a new G1 phase. We show that stathmin mRNA and protein are expressed constitutively throughout the different phases of the cell cycle. This suggests that the non-phosphorylated stathmin that predominates during G1 is not generated by degradation of phosphorylated stathmin in mitosis and synthesis of new unphosphorylated stathmin as cells enter a new G1 phase. This suggested that protein phosphatases might be responsible for dephosphorylating stathmin as cells enter a new cell cycle. Okadaic acid-mediated inhibition of protein phosphatases in vivo showed a major increase in the level of phosphorylation of stathmin. Dephosphorylation studies in vitro showed differential patterns of site-specific dephosphorylaton of stathmin to protein phosphatase type 1, protein phosphatase type 2A and protein phosphatase type 2B. Thus stathmin might be a target for okadaic acid-sensitive protein phosphatase(s), and its activity in eukaryotic cells might be modulated by the sequential activity of specific protein kinases and phosphatases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9693097      PMCID: PMC1219656          DOI: 10.1042/bj3340023

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  31 in total

1.  Dephosphorylation of distinct sites on microtubule-associated protein MAP1B by protein phosphatases 1, 2A and 2B.

Authors:  L Ulloa; V Dombrádi; J Díaz-Nido; K Szücs; P Gergely; P Friedrich; J Avila
Journal:  FEBS Lett       Date:  1993-09-06       Impact factor: 4.124

2.  Antisense RNA inhibition of phosphoprotein p18 expression abrogates the transformed phenotype of leukemic cells.

Authors:  S Jeha; X N Luo; M Beran; H Kantarjian; G F Atweh
Journal:  Cancer Res       Date:  1996-03-15       Impact factor: 12.701

Review 3.  Protein serine/threonine phosphatases: structure, regulation, and functions in cell growth.

Authors:  M C Mumby; G Walter
Journal:  Physiol Rev       Date:  1993-10       Impact factor: 37.312

4.  Regulation of phosphoprotein p18 in leukemic cells. Cell cycle regulated phosphorylation by p34cdc2 kinase.

Authors:  X N Luo; B Mookerjee; A Ferrari; S Mistry; G F Atweh
Journal:  J Biol Chem       Date:  1994-04-08       Impact factor: 5.157

5.  Calcineurin protein phosphatase activity in peripheral blood lymphocytes.

Authors:  F Rusnak; A H Beressi; A Haddy; A Tefferi
Journal:  Bone Marrow Transplant       Date:  1996-03       Impact factor: 5.483

6.  Transcriptional regulation of phosphoprotein p18 during monocytic differentiation of U937 leukemic cells.

Authors:  S Mistry; X N Luo; G F Atweh
Journal:  Cell Mol Biol Res       Date:  1995

7.  Cell-cycle-regulated phosphorylation of oncoprotein 18 on Ser16, Ser25 and Ser38.

Authors:  G Brattsand; U Marklund; K Nylander; G Roos; M Gullberg
Journal:  Eur J Biochem       Date:  1994-03-01

8.  Identification of a protein that interacts with tubulin dimers and increases the catastrophe rate of microtubules.

Authors:  L D Belmont; T J Mitchison
Journal:  Cell       Date:  1996-02-23       Impact factor: 41.582

9.  Multiple phosphorylation of stathmin. Identification of four sites phosphorylated in intact cells and in vitro by cyclic AMP-dependent protein kinase and p34cdc2.

Authors:  L Beretta; T Dobránsky; A Sobel
Journal:  J Biol Chem       Date:  1993-09-25       Impact factor: 5.157

10.  The phosphorylation state of tau in the developing rat brain is regulated by phosphoprotein phosphatases.

Authors:  M Mawal-Dewan; J Henley; A Van de Voorde; J Q Trojanowski; V M Lee
Journal:  J Biol Chem       Date:  1994-12-09       Impact factor: 5.157

View more
  16 in total

1.  Protein phosphatase 2A is associated in an inactive state with microtubules through 2A1-specific interaction with tubulin.

Authors:  A Hiraga; S Tamura
Journal:  Biochem J       Date:  2000-03-01       Impact factor: 3.857

2.  KIAA1199 promotes metastasis of colorectal cancer cells via microtubule destabilization regulated by a PP2A/stathmin pathway.

Authors:  Lei Zhao; Dejun Zhang; Qiong Shen; Min Jin; Zhenyu Lin; Hong Ma; Shaoyi Huang; Pengfei Zhou; Gang Wu; Tao Zhang
Journal:  Oncogene       Date:  2018-09-10       Impact factor: 9.867

3.  Hedgehog signaling regulates proliferation of prostate cancer cells via stathmin1.

Authors:  Moon-Kee Chung; Hyun-Jung Kim; Young-Suk Lee; Myoung-Eun Han; Sik Yoon; Sun-Yong Baek; Bong-Seon Kim; Jae-Bong Kim; Sae-Ock Oh
Journal:  Clin Exp Med       Date:  2009-09-25       Impact factor: 3.984

4.  RSK2 signals through stathmin to promote microtubule dynamics and tumor metastasis.

Authors:  G N Alesi; L Jin; D Li; K R Magliocca; Y Kang; Z G Chen; D M Shin; F R Khuri; S Kang
Journal:  Oncogene       Date:  2016-04-04       Impact factor: 9.867

5.  Merkel cell polyomavirus small T antigen mediates microtubule destabilization to promote cell motility and migration.

Authors:  Laura M Knight; Gabriele Stakaityte; Jennifer J Wood; Hussein Abdul-Sada; David A Griffiths; Gareth J Howell; Rachel Wheat; G Eric Blair; Neil M Steven; Andrew Macdonald; David J Blackbourn; Adrian Whitehouse
Journal:  J Virol       Date:  2014-10-15       Impact factor: 5.103

6.  The Fanconi Anemia C Protein Binds to and Regulates Stathmin-1 Phosphorylation.

Authors:  Audrey Magron; Sabine Elowe; Madeleine Carreau
Journal:  PLoS One       Date:  2015-10-14       Impact factor: 3.240

7.  Overexpression of stathmin1 in the diffuse type of gastric cancer and its roles in proliferation and migration of gastric cancer cells.

Authors:  T-Y Jeon; M-E Han; Y-W Lee; Y-S Lee; G-H Kim; G-A Song; G-Y Hur; J-Y Kim; H-J Kim; S Yoon; S-Y Baek; B-S Kim; J-B Kim; S-O Oh
Journal:  Br J Cancer       Date:  2010-01-19       Impact factor: 7.640

8.  MiR-101 is involved in human breast carcinogenesis by targeting Stathmin1.

Authors:  Rui Wang; Hong-Bin Wang; Chan Juan Hao; Yi Cui; Xiao-Chen Han; Yi Hu; Fei-Feng Li; Hong-Fei Xia; Xu Ma
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

Review 9.  Stathmin 1 in normal and malignant hematopoiesis.

Authors:  João Agostinho Machado-Neto; Sara Teresinha Olalla Saad; Fabiola Traina
Journal:  BMB Rep       Date:  2014-12       Impact factor: 4.778

10.  Stathmin dynamics modulate the activity of eribulin in breast cancer cells.

Authors:  Mikihiro Yoshie; Akari Ishida; Haruka Ohashi; Nami Nakachi; Mana Azumi; Kazuhiro Tamura
Journal:  Pharmacol Res Perspect       Date:  2021-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.